International Biotechnology Trust (IBT)
Category Sector Equity Biotechnology
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
568.00p
Buy
574.00p
20.00p (+3.64%)
Discount/Premium
-12.42%
Estimated NAV
628.011p
Prices updated at 16 May 2025, 14:28 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- News & dates
- Trust info
- Director info
| 550.00 | |
| Launch date | 06 May 1994 |
| 572.00p - 556.00p | |
| 736.00p - 480.00p | |
| 615.94 as of 14 May 2025 | |
| Ongoing charge audited (%) | 1.2 |
| 1.5 | |
| 0.06 | |
| 4.47 | |
| 87,493.75 | |
| 35.09m | |
| 193.02m | |
| 105.84 | |
| Semi-Annually | |
| £258.04m | |
| £223.19m | |
| -9.99 | |
| -10.08 | |
| -7.70 | |
| Fund comparative index | Nasdaq Biotechnology Index |
| Daily | |
| 0.08m | |
| 0.51m | |
| GB0004559349 |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.
